Stay updated on SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial
Sign up to get notified when there's something new on the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page.

Latest updates to the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe record adds a new revision tag v3.6.0 and includes a note that the study is no longer recruiting participants; the older revision tag v3.5.5 is removed.SummaryDifference0.5%

- Check19 days agoChange DetectedAn updated revision entry v3.5.5 has been added to the study record history, signaling a new version of the record. The previous revision v3.5.4 has been removed from the current history.SummaryDifference0.1%

- Check26 days agoChange DetectedVersion history for the study was updated to include new entries and sections (2026-05-21 version 15, and 2026-05-27 additions for References, Study Design, and Study Status). The note about early discontinuation was added on 2026-05-27, and the earlier 2025-06-12 instance of that note was removed.SummaryDifference0.6%

- Check40 days agoChange DetectedThe record history now includes a new revision entry v3.5.4. The previous revision v3.5.3 has been removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s interface/version label was updated from one revision to a newer revision. This reflects a site or software update rather than a change to the underlying clinical trial record content.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.5.2 was added and an older revision v3.5.0 was removed from the study record versions. This reflects a minor update to the revision history without altering study data or details.SummaryDifference0.1%

Stay in the know with updates to SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page.